Skip to main content
. 2020 Nov 5;21(12):1097–1104. doi: 10.1080/15384047.2020.1834319

Figure 2.

Figure 2.

CT scan and tumor markers of the patient experienced HPD after nivolumab treatment. (a) The CT scan before and after nivolumab treatment. In this case, HPD was defined as a disease condition after anti-PD1/PD-L1 treatment which has a short TTF (less than 1 month) and a more than 50% increase than baseline in the size of the lesion. (b) The alterations in tumor markers during nivolumab treatment